Fisher Wallace Neurostimulation & Depression Study
Fisher Wallace Neurostimulation & Depression Study
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator
 Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight
 weeks.
Inclusion criteria:

 -  Age greater than or equal to 21

 -  US resident

 -  Can receive packages to their home via UPS/Fedex/USPS

 -  Major Depressive Disorder

 -  PHQ-8 Score greater than 10 (show some signs of mild to moderate depression)

 -  PHQ-8 Score less than 20 (given remote study serious depressed should be excluded)

 -  Read/write English

 -  have not contemplated suicide in the past year

 -  not been institutionalized for mental health issues.

 -  not currently experiencing problems with alcohol or drug abuse

 -  can commit to not drinking alcohol 4 hours before bedtime for the duration of the
 study

 -  can commit to two (2) 20 minute sessions per day for 8 weeks

 -  has not used a brain stimulation treatment in one year

 -  no suspected or known history of heart disease

 -  no pacemaker

 -  not under medical supervision for other serious medical condition

 -  not taking opioids

 -  is a resident of states in which we have licensed medical professionals